Delivery Order HT942523D0002-HT942524F0078

Award Date 5/13/24
Potential Completion Date 5/12/25
Potential Value $740K
Ultimate Awardee
Leidos Holdings, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Fort Detrick, MD 21702, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Cost Plus Fixed Fee delivery order contract awarded by the Defense Health Agency (DHA) to Leidos, Inc. for Peer Reviewed Cancer Research Program (PRCRP) meeting services. The contract has a total ceiling value of $1,454,028.68 and a period of performance through May 12, 2023. The contract was not set aside for any specific business category. Leidos, Inc., a global technology and engineering solutions provider, is the prime contractor on this award. The contract supports critical...
The Department of the Army Medical Command awarded a cost-plus-fixed-fee delivery order contract to Leidos, Inc. worth $344,861.84 for meeting support services related to the Peer Reviewed Cancer Research Program (PRCRP). The contract involves the peer review of research proposals received under the PRCRP. The contract is not designated as a set-aside. Leidos, Inc. is a global provider of information technology, engineering, and science solutions, operating through various subsidiaries and...
This is a $1,194,974.16 cost-plus-fixed-fee delivery order contract awarded by the Defense Health Agency to Leidos, Inc. for the Peer Reviewed Medical Research Program. The contract has a performance period ending on March 18, 2026. Leidos, a global technology and engineering solutions provider, will support critical medical research and development efforts across various domains for the Defense Health Agency, including work on traumatic brain injury, cancer, autism, and rare diseases. This...
This contract was awarded by the Medical Command (MEDCOM), a subcomponent of the U.S. Army, to Leidos, Inc. for general program support related to the Peer Reviewed Cancer Research Program (PRCRP) for fiscal year 2015. The contract is a delivery order with a time and materials pricing type and a ceiling value of $270,508.28. The period of performance runs through June 25, 2016. The contract was not set aside for a specific business category. This award is associated with Leidos' existing...
The Defense Health Agency awarded a $549,344.15 cost-plus-fixed-fee delivery order contract to Leidos, Inc. for peer reviewed medical research program support services. This work supports the Congressionally Directed Medical Research Programs. The contract was not set aside. Leidos, Inc. is a global leader in information technology, engineering, and science solutions, providing a wide range of products and services to U.S. government agencies, primarily in the areas of national security, health,...
This federal contract award is for breast cancer research program support services for the Congressionally Directed Medical Research Programs, administered by the Defense Health Agency (DHA). The prime contractor is Leidos, Inc., a global technology and engineering solutions provider that supports critical missions across national security, health, and other federal domains. The contract has a ceiling value of $571,801.10 and a period of performance through December 1, 2025. It is a...
This is a $208,476.31 cost-plus-fixed-fee delivery order awarded by the Department of the Army Medical Command to Leidos, Inc. to provide FY 2017 Peer Reviewed Cancer Research Program (PRCRP) support. The contract has a completion date of September 30, 2018 and was awarded on September 15, 2017. It does not have a set-aside designation. Leidos, Inc., a global leader in IT, engineering, and scientific solutions, is performing this work through its Leidos Services Operating Segment, doing business...
This contract was awarded by the Defense Health Agency to Leidos, Inc. for the Lung Cancer Research Program (LCRP). The $368,323.90 cost-plus-fixed-fee delivery order contract has a period of performance through March 31, 2026. The contract was not set aside for any specific business category. Leidos, a global technology and engineering solutions provider, will deliver medical research program support to the Defense Health Agency. This contract aligns with the agency's mission to provide...
This federal contract award is for the Fiscal Year 2024 Peer Reviewed Medical Research Program Support and was issued by the Defense Health Agency, a defense agency, to the prime contractor Leidos, Inc. The contract has a potential ceiling value of $1,278,199.25 and is a Cost Plus Fixed Fee Delivery Order type contract. The contract is not set aside for any specific business category. The contract scope includes research and development, systems integration, and program management services to...
Leidos, Inc., doing business as Saic, was awarded a $479,686.83 cost-plus-fixed-fee delivery order by the Defense Health Agency to provide FY19 PCRP Meeting, Scientific, and Administrative Support Services from May 1, 2019 through April 30, 2020. As the prime contractor, Leidos will support the Peer Reviewed Cancer Research Program with meeting, scientific, and administrative assistance at Fort Detrick, Maryland. No set-aside designation was applied to this order. Leidos has extensive experience...
  • HT942523D0002
    Indefinite Delivery Contract
  • HT942523D0002-HT942524F0078
    Delivery Order

This federal contract award to Leidos, Inc. provides support services for the Peer Review Cancer Research Program (PRCRP) under the Congressionally Directed Medical Research Programs. The $739,649.10 cost-plus-fixed-fee delivery order contract has a completion date of May 12, 2025 and was issued by the Defense Health Agency. Leidos, a global technology and engineering solutions provider, will deliver a range of technical, scientific, and administrative services to support critical medical research efforts. The contract is not set aside for any specific business category, indicating Leidos' competitive capabilities across federal procurement. Leidos is a subsidiary of the parent company Leidos Holdings, Inc., which holds several significant Indefinite Delivery Contracts (IDCs) with federal agencies for medical services, healthcare infrastructure, and comprehensive examination programs.

Generated 5/23/25, 9:43 AM